Hrs inhibits citron kinase-mediated HIV-1 budding via its FYVE domain

Abstract

Hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs) is a key component of the endosomal sorting complexes required for transport and has been demonstrated to play a regulatory role in endocytosis/exocytosis and the accumulation of internal vesicles in multivesicular bodies. Citron kinase is a Ser/The kinase that we previously reported to enhance human immunodeficiency virus type 1 (HIV-1) virion production. However, the relationship between Hrs and citron kinase in HIV-1 production remains elusive. Here, we report that Hrs interacts with citron kinase via its FYVE domain. Overexpression of Hrs or the FYVE domain resulted in a significant decrease in HIV-1 virion production. Depletion of Hrs by RNA interference in HEK293T cells increased HIV-1 virion production and enhanced the activity of citron kinase. These data suggest that Hrs inhibits HIV-1 production by inhibiting citron kinase-mediated exocytosis.

Keywords

citron kinase / Hrs / HIV-1 budding

References

[1] Bache, K.G., Brech, A., Mehlum, A., and Stenmark, H. (2003). Hrs regulates multivesicular body formation via ESCRT recruitment to endosomes.J Cell Biol 162, 435-442 .12900395
[2] Bean, A.J., Seifert, R., Chen, Y.A., Sacks, R., and Scheller, R.H. (1997). Hrs-2 is an ATPase implicated in calcium-regulated secretion.Nature 385, 826-829 .9039916
[3] Bouamr, F., Houck-Loomis, B.R., De Los Santos, M., Casaday, R.J., Johnson, M.C., and Goff, S.P. (2007). The C-terminal portion of the Hrs protein interacts with Tsg101 and interferes with human immunodeficiency virus type 1 Gag particle production.J Virol 81, 2909-2922 .17182674
[4] Bouamr, F., Melillo, J.A., Wang, M.Q., Nagashima, K., de Los Santos, M., Rein, A., and Goff, S.P. (2003). PPPYVEPTAP motif is the late domain of human T-cell leukemia virus type 1 Gag and mediates its functional interaction with cellular proteins Nedd4 and Tsg101 [corrected].J Virol 77, 11882-11895 .14581525
[5] Dong, X., Li, H., Derdowski, A., Ding, L., Burnett, A., Chen, X., Peters, T.R., Dermody, T.S., Woodruff, E., Wang, J.J., (2005). AP-3 directs the intracellular trafficking of HIV-1 Gag and plays a key role in particle assembly.Cell 120, 663-674 .15766529
[6] Finzi, A., Orthwein, A., Mercier, J., and Cohen, E.A. (2007). Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane.J Virol 81, 7476-7490 .17507489
[7] Kwong, J., Roundabush, F.L., Hutton Moore, P., Montague, M., Oldham, W., Li, Y., Chin, L.S., and Li, L. (2000). Hrs interacts with SNAP-25 and regulates Ca(2+)-dependent exocytosis.J Cell Sci 113, 2273-2284 .10825299
[8] Loomis, R.J., Holmes, D.A., Elms, A., Solski, P.A., Der, C.J., and Su, L. (2006). Citron kinase, a RhoA effector, enhances HIV-1 virion production by modulating exocytosis.Traffic 7, 1643-1653 .17118119
[9] Mai, Y., and Gao, G. (2010). Expression of IMP1 enhances production of murine leukemia virus vector by facilitating viral genomic RNA packaging.PLoS One 5, e15881.21209918
[10] McCullough, J., Fisher, R.D., Whitby, F.G., Sundquist, W.I., and Hill, C.P. (2008). ALIX-CHMP4 interactions in the human ESCRT pathway.Proc Natl Acad Sci U S A 105, 7687-7691 .18511562
[11] Mills, I.G., Jones, A.T., and Clague, M.J. (1998). Involvement of the endosomal autoantigen EEA1 in homotypic fusion of early endosomes.Curr Biol 8, 881-884 .9705936
[12] Ono, A., and Freed, E.O. (2004). Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body.J Virol 78, 1552-1563 .14722309
[13] Paillart, J.C., and G?ttlinger, H.G. (1999). Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of gag membrane targeting.J Virol 73, 2604-2612 .10074105
[14] Perez-Caballero, D., Zang, T., Ebrahimi, A., McNatt, M.W., Gregory, D.A., Johnson, M.C., and Bieniasz, P.D. (2009). Tetherin inhibits HIV-1 release by directly tethering virions to cells.Cell 139, 499-511 .19879838
[15] Pornillos, O., Alam, S.L., Davis, D.R., and Sundquist, W.I. (2002). Structure of the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6 protein.Nat Struct Biol 9, 812-817 .12379843
[16] Pridgeon, J.W., Webber, E.A., Sha, D., Li, L., and Chin, L.S. (2009). Proteomic analysis reveals Hrs ubiquitin-interacting motif-mediated ubiquitin signaling in multiple cellular processes.FEBS J 276, 118-131 .19019082
[17] Simonsen, A., Lippé, R., Christoforidis, S., Gaullier, J.M., Brech, A., Callaghan, J., Toh, B.H., Murphy, C., Zerial, M., and Stenmark, H. (1998). EEA1 links PI(3)K function to Rab5 regulation of endosome fusion.Nature 394, 494-498 .9697774
[18] Spearman, P., Horton, R., Ratner, L., and Kuli-Zade, I. (1997). Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism.J Virol 71, 6582-6592 .9261380
[19] Strack, B., Calistri, A., Craig, S., Popova, E., and G?ttlinger, H.G. (2003). AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding.Cell 114, 689-699 .14505569
[20] Stuchell-Brereton, M.D., Skalicky, J.J., Kieffer, C., Karren, M.A., Ghaffarian, S., and Sundquist, W.I. (2007). ESCRT-III recognition by VPS4 ATPases.Nature 449, 740-744 .17928862
[21] Tang, C., Loeliger, E., Luncsford, P., Kinde, I., Beckett, D., and Summers, M.F. (2004). Entropic switch regulates myristate exposure in the HIV-1 matrix protein.Proc Natl Acad Sci U S A 101, 517-522 .14699046
[22] VerPlank, L., Bouamr, F., LaGrassa, T.J., Agresta, B., Kikonyogo, A., Leis, J., and Carter, C.A. (2001). Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag).Proc Natl Acad Sci U S A 98, 7724-7729 .11427703
[23] Zhai, Q., Fisher, R.D., Chung, H.Y., Myszka, D.G., Sundquist, W.I., and Hill, C.P. (2008). Structural and functional studies of ALIX interactions with YPX(n)L late domains of HIV-1 and EIAV.Nat Struct Mol Biol 15, 43-49 .18066081
[24] Zhou, W., and Resh, M.D. (1996). Differential membrane binding of the human immunodeficiency virus type 1 matrix protein.J Virol 70, 8540-8548 .8970978